Stifel Financial Corp Has $965,000 Stock Holdings in Aemetis, Inc. (NASDAQ:AMTX)

Stifel Financial Corp trimmed its holdings in Aemetis, Inc. (NASDAQ:AMTX) by 41.7% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 419,494 shares of the specialty chemicals company’s stock after selling 299,669 shares during the period. Stifel Financial Corp owned 0.84% of Aemetis worth $965,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Susquehanna Fundamental Investments LLC boosted its holdings in Aemetis by 287.4% in the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock worth $379,000 after purchasing an additional 93,536 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in shares of Aemetis during the 2nd quarter worth about $306,000. Rhumbline Advisers boosted its stake in shares of Aemetis by 2,837.1% during the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after acquiring an additional 50,528 shares in the last quarter. Hutchinson Capital Management CA acquired a new position in shares of Aemetis during the 2nd quarter valued at about $70,000. Finally, FMR LLC raised its stake in shares of Aemetis by 68.2% in the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after acquiring an additional 9,137 shares in the last quarter. Institutional investors and hedge funds own 27.02% of the company’s stock.

Aemetis Stock Down 1.1 %

Shares of NASDAQ AMTX opened at $2.59 on Tuesday. Aemetis, Inc. has a 12 month low of $2.10 and a 12 month high of $7.03. The company has a market cap of $128.81 million, a P/E ratio of -1.15 and a beta of 1.35. The business’s 50 day moving average is $3.30 and its two-hundred day moving average is $3.00.

Aemetis (NASDAQ:AMTX) last announced its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The company had revenue of $81.44 million for the quarter, compared to the consensus estimate of $77.79 million. During the same period last year, the firm posted ($0.59) EPS. Sell-side analysts expect that Aemetis, Inc. will post -2.02 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

AMTX has been the topic of several analyst reports. Ascendiant Capital Markets lowered their price target on Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a report on Tuesday, September 3rd. HC Wainwright reiterated a “buy” rating and issued a $28.00 target price on shares of Aemetis in a research note on Monday. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $12.95.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.